Trial intelligence / Profile preview

Lignocaine with intramuscular amikacin in children with drug-resistant tuberculosis

PACTR201401000670381Recruiting

Sponsor
Stellenbosch University
Start
Jul 2013
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of lidocaine and amikacin in Tuberculosis (TB) (2 arms), sponsored by Stellenbosch University. Primary endpoints: Change in pain intensity and Amikacin pharmacokinetics. Started Jul 2013; status: recruiting.

02

Drugs

lidocaineamikacin
03

Conditions

Tuberculosis (TB)

Beyond the preview

Go deeper on PACTR201401000670381.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201401000670381.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call